RTI-353

RTI(-4229)-353 is a phenyltropane derived drug which acts as an SSRI.[1] Tamagnan et al. also made some phenyltropanes with high activity and selectivity for the SERT (pM affinity).[2]

RTI-353
Identifiers
IUPAC name
  • methyl (1R,2S,3S,5S)-3-(4-ethyl-3-iodophenyl)-8-azabicyclo[3.2.1]octane-2-carboxylate
CAS Number
PubChem CID
UNII
Chemical and physical data
FormulaC17H22INO2
Molar mass399.272 g·mol−1
3D model (JSmol)
SMILES
  • CCC1=C(C=C(C=C1)[C@H]2C[C@@H]3CC[C@H]([C@H]2C(=O)OC)N3)I
  (verify)

See also

References
  1. Navarro HA, Xu H, Zhong D, Blough BE, Ross WP, Kuhar MJ, Carroll FI (September 2001). "[(125)I]3beta-(4-ethyl-3-iodophenyl)nortropane-2beta-carboxylic acid methyl ester ([(125)I]EINT): a potent and selective radioligand for the brain serotonin transporter". Synapse. New York, N.Y. 41 (3): 241–7. doi:10.1002/syn.1081. PMID 11418937. S2CID 2323766.
  2. Tamagnan G, Alagille D, Fu X, Kula NS, Baldessarini RJ, Innis RB, Baldwin RM (January 2006). "Synthesis and monoamine transporter affinity of new 2beta-carbomethoxy-3beta-[aryl or heteroaryl]phenyltropanes". Bioorganic & Medicinal Chemistry Letters. 16 (1): 217–20. doi:10.1016/j.bmcl.2005.09.016. PMID 16236497.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.